E. Garry Menzel - Insider Trading & Ownership

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 3545 John Hopkins Court Suite 210, San Diego, California
Summary
The estimated net worth of E. Garry Menzel is at least $50.5 K dollars as of July 1, 2024. E. Garry Menzel is the Director of Adaptimmune Therapeutics PLC and owns shares of Adaptimmune Therapeutics PLC (ADAP) stock worth about $50.5 K.
All Insider Reports
All Insider Reports

Ownership of E. Garry Menzel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ADAP Adaptimmune Therapeutics PLC Director $50.5 K -$43.4 K -46.2% Jul 1, 2024
BDTX Black Diamond Therapeutics, Inc. Director Jun 6, 2024
STOK Stoke Therapeutics, Inc. Director Jun 5, 2024
TCRR TCR2 THERAPEUTICS INC. President and CEO, Director Jun 1, 2023

Insider Transactions Reported by E. Garry Menzel:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership